Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-24 @ 11:36 PM
NCT ID:
NCT06415656
Eligibility Criteria:
Inclusion Criteria:
1. Adults at or over the age of 18 with hematologic malignancies undergoing treatment with chimeric antigen receptor (CAR) T-cell therapy or bispecific T-cell engagers (BiTE), as follows:
* Axicabtagene ciloleucel
* Lisocabtagene maraleucel
* Brexucabtagene autoleucel
* Idecabtagene vicleucel
* Ciltacabtagene autoleucel
* Obecabtagene autoleucel
* Tisagenlecleucel
* Blinatumomab
* Mosunetuzumab
* Talquetamab
* Elranatamab
* Teclistamab
* Glofitamab
2. Owns a smart phone (e.g., iPhone, Android, Samsung) that is compatible with the VitalTraq app and that can connect to wi-fi. This will be assessed at screening.
3. Able to read and understand English
4. Willing and able to provide informed consent to the study
Exclusion Criteria:
1. Receiving a non-FDA approved CAR-T or BiTE product
2. Receiving Epcoritamab
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06415656
Study Brief:
Protocol Section:
NCT06415656